Navigation Links
Epiomic Epidemiology Series: Rheumatoid Arthritis Forecast in 17 Major Markets 2016-2026
Date:11/16/2016

NEW YORK, Nov. 16, 2016 /PRNewswire/ -- Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Rheumatoid Arthritis in 17 Major Markets

Rheumatoid arthritis (RA) is classified as an autoimmune disease and occurs when the immune system attacks the synovium (membranes surrounding joints). The inflammation resulting from the attack causes thickening of the synovium, which eventually destroys the cartilage and bone within the joint. The tendons and ligaments holding the joint together weaken and stretch, resulting in gradual loss of joint shape and alignment.

Prevalence of RA has been rumoured to be in decline over the past 20-30 years, although there is nothing concrete in the literature to substantiate if this is actually the case.
This report provides the current prevalent population for Rheumatoid Arthritis across 17 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, NL, Denmark, Norway, Greece, Turkey, Brazil, Mexico, Argentina, Japan and India) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Rheumatoid Arthritis have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

The following are considered features or comorbid conditions associated with RA:
- Smoking
- Obesity
- Diabetes
- Metabolic syndrome
- Hypertension
- Extra-articular manifestations
- Erosive disease
- Cachexia (muscle wasting)

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy
- Able to quantify patient populations in the global Rheumatoid Arthritis market to target the development of future products, pricing strategies and launch plans.
- Gain further insight into the prevalence of the subdivided types of Rheumatoid Arthritis and identify patient segments with high potential.
- Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
- Provide a level of understanding on the impact from specific co-morbid conditions on Rheumatoid Arthritis's prevalent population.
- Identify sub-populations within Rheumatoid Arthritis which require treatment.
- Gain an understanding of the specific markets that have the largest number of Rheumatoid Arthritis patients.

Read the full report: http://www.reportlinker.com/p04208329-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/epiomic-epidemiology-series-rheumatoid-arthritis-forecast-in-17-major-markets-2016-2026-300364691.html


'/>"/>
SOURCE Reportlinker
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. EpiCast Report: Gram-Negative Bacterial Pneumonia - Epidemiology Forecast to 2022
2. EpiCast Report: Atrial Fibrillation - Epidemiology Forecast to 2023
3. Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers
4. EpiCast Report: Age-Related Macular Degeneration - Epidemiology Forecast to 2023
5. EpiCast Report: Breast Cancer (HER2-, HER2+) - Epidemiology Forecast to 2023
6. EpiCast Report: Diabetic Macular Edema - Epidemiology Forecast to 2023
7. EpiCast Report: Sepsis - Epidemiology Forecast to 2023
8. Mapi integrates Epidemiology, HEOR and Strategic Market Access into Real World Strategy and Analytics
9. Mapi intègre les services Epidemiology, HEOR (Health Economics Outcomes Research) et Strategic Market Access dans son département Real World Strategy and Analytics
10. 2015-2019 Global Tuberculosis Diagnostic Testing Market - Current scientific Views on the Tuberculosis Definition, Epidemiology and Etiology are Reviewed
11. VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2018)... NEW YORK (PRWEB) , ... August 17, 2018 , ... ... today by an unknown competitor as shown in this video . Carroll, who ... to give up his crown to an unknown man who beat Carroll’s record by ...
(Date:8/15/2018)... GRAND RAPIDS, Mich. (PRWEB) , ... August 15, ... ... announce an addition to their expansive lineup of casters. The newly designed ... ease of movement and stability. Manufactured with an antimicrobial compound injected into ...
(Date:8/11/2018)... ... ... US Capital Global has been retained by Carepoynt as its Series ... emerging leader in the digital health field. The company is dedicated to putting patients ... Headquartered in San Francisco, US Capital Global is a full-service private financial group with ...
Breaking Medicine Technology:
(Date:8/14/2018)... ... August 14, 2018 , ... ... the Recreational Group, a leading provider of residential and commercial recreational surfacing products ... sports surfacing industry, with products used across a wide range of markets and ...
(Date:8/11/2018)... ... August 10, 2018 , ... TopConsumerReviews.com ... Relief. , What is gout? This painful, persistent condition originates in the liver ... high levels of uric acid. Other contributing factors may be medication side effects, ...
(Date:8/11/2018)... ... August 11, 2018 , ... Financial Voyages ... in the Executive of the Year-Business category in The 15th Annual International Business ... All individuals and organizations worldwide – public and private, for-profit and non-profit, large ...
(Date:8/9/2018)... ... August 09, 2018 , ... ... is a new verification process that substance abuse providers must pass in order ... we can reach more people to help.” , Helping people is what ...
(Date:8/9/2018)... ... 09, 2018 , ... Thanks to the generosity of ... customers, and employees, the newly established Isagenix Legacy Foundation raised $2.3 ... 100 percent of the donations will fund grants to nonprofit organizations that further ...
Breaking Medicine News(10 mins):